Jones B A, Meier F, Howanitz P J
Department of Pathology, St John Hospital and Medical Center, Detroit, Mich. 48236.
Arch Pathol Lab Med. 1995 Mar;119(3):203-8.
to determine the frequency and reasons for rejection of specimens submitted to the laboratory for complete blood count studies.
College of American Pathologists' Q-Probes laboratory quality improvement study prospective recording of rejected complete blood count specimens and associated factors in 703 laboratories.
Percentage of submitted specimens rejected for testing.
Of 7,894,882 complete blood count specimens submitted for testing to the participating laboratories during the data collection period, 35,347 (0.45%) were rejected. The most frequent reason for rejection was a clotted specimen, which occurred about six times more frequently than the second most cited reason, insufficient specimen quantity. Compared with their respective frequency of use for specimen collection, significantly more rejected specimens were collected in microtubes than in other containers. Compared with the respective frequency with which they collect specimens, laboratory personnel had significantly fewer rejected specimens than the other personnel groups. The poorest performance was exhibited by other in-hospital nonlaboratory personnel. Hospital bedsize was also a significant performance factor; smaller hospitals demonstrated lower rejection percentages.
Specimen rejection should be monitored on a regular basis, identifying institution-specific factors that are associated with rejection. Monitoring of sufficient significant variables will help narrow the focus of corrective action. Action thresholds should be set sufficiently low to assure ongoing efforts toward improvement.
确定提交至实验室进行全血细胞计数研究的标本被拒收的频率及原因。
美国病理学家学会的Q-Probes实验室质量改进研究,前瞻性记录703家实验室中被拒收的全血细胞计数标本及相关因素。
提交的标本被拒收用于检测的百分比。
在数据收集期间,提交至参与研究实验室进行检测的7,894,882份全血细胞计数标本中,有35,347份(0.45%)被拒收。最常见的拒收原因是标本凝血,其发生频率比第二常见原因标本量不足高出约6倍。与各自用于标本采集的频率相比,微管采集的被拒收标本明显多于其他容器采集的。与各自采集标本的频率相比,实验室人员的被拒收标本明显少于其他人员组。医院内其他非实验室人员的表现最差。医院病床规模也是一个重要的表现因素;规模较小的医院拒收百分比更低。
应定期监测标本拒收情况,识别与拒收相关的机构特定因素。监测足够多的重要变量将有助于缩小纠正措施的关注范围。行动阈值应设定得足够低,以确保持续努力改进。